Table 3 Adverse events observed in 46 patients
From: Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer
Number of patients grade a | |||
|---|---|---|---|
Adverse events | 3 | 4 | Number of patients(%) grade 3 or 4 |
Neutropenia | 15 | 16 | 31 (67) |
Leucopenia | 16 | 3 | 19 (41) |
Anaemia | 9 | 1 | 10 (22) |
Anorexia | 10 | 0 | 10 (22) |
Hyponatremia | 8 | 0 | 8 (17) |
Nausea | 4 | 0 | 4 (9) |
Vomiting | 1 | 0 | 1 (2) |
Stomatitis | 3 | 0 | 3 (7) |
Diarrhoea | 2 | 0 | 2 (4) |
AST elevation | 3 | 0 | 3 (7) |
Infection | 2 | 0 | 2 (4) |
